143 related articles for article (PubMed ID: 9859833)
1. Combined cell sorting and FISH for detection of minimal residual disease in bone marrow of children with acute leukemia or solid tumors.
Sainati L; Spinelli M; Leszl A; Cocito MG; Stella M; Basso G
Eur J Histochem; 1997; 41 Suppl 2():167-8. PubMed ID: 9859833
[No Abstract] [Full Text] [Related]
2. Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases.
Cambier N; Soenen-Cornu V; Laï JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 2000 Jun; 85(6):664-5. PubMed ID: 10870127
[No Abstract] [Full Text] [Related]
3. [Minimal residual disease. Methodologies and clinical implications].
Ortega M; Coll MD; Solé F; Caballín MR
Sangre (Barc); 1999 Aug; 44(4):283-90. PubMed ID: 10589280
[No Abstract] [Full Text] [Related]
4. Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.
Lambooy LH; Gidding CE; van den Heuvel LP; Hulsbergen-van de Kaa CA; Ligtenberg M; Bökkerink JP; De Abreu RA
Clin Cancer Res; 2003 Feb; 9(2):812-9. PubMed ID: 12576454
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods.
Zwick D; Cooley L; Hetherington M
Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow.
Okcu MF; Wang RY; Bueso-Ramos C; Schober W; Weidner D; Andrassy R; Blakely M; Russell H; Ozkan A; Kuttesch J; Andreeff M; Chan KW; Ater J
Pediatr Blood Cancer; 2005 Nov; 45(6):787-95. PubMed ID: 15929127
[TBL] [Abstract][Full Text] [Related]
7. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
[TBL] [Abstract][Full Text] [Related]
8. Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in children with acute leukemia and neuroblastoma.
Markaki EA; Tsopanomichalou M; Dimitriou H; Stiakaki E; Perdikoyanni C; Spandidos D; Kalmanti M
Pediatr Hematol Oncol; 2001 Mar; 18(2):101-10. PubMed ID: 11255727
[TBL] [Abstract][Full Text] [Related]
9. Aneuploidy as a marker of minimal residual disease in leukemia.
Walle AJ; Niedermayer W
Cancer Detect Prev; 1985; 8(1-2):303-15. PubMed ID: 4064049
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of minimal residual disease in autologous bone marrow transplantation].
Jørgensen H; Bukh A; Hokland P; Ellegaard J; Madsen PS; Hokland M
Nord Med; 1996 Dec; 111(10):344-7. PubMed ID: 8992466
[TBL] [Abstract][Full Text] [Related]
11. Detection and monitoring of minimal residual disease by quantitative real-time PCR.
Schüler F; Dölken G
Clin Chim Acta; 2006 Jan; 363(1-2):147-56. PubMed ID: 16154122
[TBL] [Abstract][Full Text] [Related]
12. Automated detection of residual leukemic cells by consecutive immunolabeling for CD10 and fluorescence in situ hybridization for ETV6/RUNX1 rearrangement in childhood acute lymphoblastic leukemia.
Alpár D; Kajtár B; Kneif M; Jáksó P; László R; Kereskai L; Pajor L
Cancer Genet Cytogenet; 2007 Feb; 173(1):23-30. PubMed ID: 17284366
[TBL] [Abstract][Full Text] [Related]
13. Detection and treatment of minimal residual disease in high-risk neuroblastoma.
Reynolds CP
Pediatr Transplant; 2004 Jun; 8 Suppl 5():56-66. PubMed ID: 15125707
[TBL] [Abstract][Full Text] [Related]
14. Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?
Aricò M; Germano G; del Giudice L; Ziino O; Locatelli F; Basso G
Haematologica; 2002 Apr; 87(4):ELT19. PubMed ID: 11940504
[No Abstract] [Full Text] [Related]
15. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
Slovak ML; Tcheurekdjian L; Zhang FF; Murata-Collins JL
Cancer Res; 2001 Feb; 61(3):831-6. PubMed ID: 11221864
[TBL] [Abstract][Full Text] [Related]
17. Assessment of minimal residual disease in patients with acute leukemia.
Baer MR
Curr Opin Oncol; 1998 Jan; 10(1):17-22. PubMed ID: 9466480
[TBL] [Abstract][Full Text] [Related]
18. Quantifying leukemia.
Morley A
N Engl J Med; 1998 Aug; 339(9):627-9. PubMed ID: 9718385
[No Abstract] [Full Text] [Related]
19. Necessity of bilateral bone marrow biopsies for ancillary cytogenetic studies in the pediatric population.
Grimm KE; Chen C; Weiss LM
Am J Clin Pathol; 2010 Dec; 134(6):982-6. PubMed ID: 21088163
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K
Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
